Alpha 2.0
Login Register
» Authors » Prasanna Raj Supramaniam

Prasanna Raj Supramaniam

Explore the profile of Prasanna Raj Supramaniam including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 37
Followers 0
Related Specialties
General Medicine
Reproductive Medicine
Gynecology & Obstetrics
Top 10 Co-Authors
Monica Mittal
Lee Nai Lim
Haitham Hamoda
Mike Savvas
Linda Cardozo
Enda McVeigh
Ingrid Granne
Nick Panay
Roopen Arya
Ruoxing Du
Published In
Reprod Health
BMJ Case Rep
J Clin Med
GMS J Med Educ
Menopause
Affiliations
Soon will be listed here.
Recent Articles
1.
Safe Service Delivery of a Complex Early Pregnancy Problem: Caesarean Scar Pregnancy
Fourie H, El-Zibdeh A, Heppell V, Granne I, Lim L, Supramaniam P
J Clin Med . 2022 Dec; 11(23). PMID: 36498640
Caesarean Scar Pregnancy (CSP) is an ectopic pregnancy with implantation into the niche of the uterine scar. We aimed to describe the local management of consecutive cases of CSP to...
2.
Impact of micronised progesterone and medroxyprogesterone acetate in combination with transdermal oestradiol on cardiovascular markers in women diagnosed with premature ovarian insufficiency or an early menopause: a randomised pilot trial
Mittal M, McEniery C, Supramaniam P, Cardozo L, Savvas M, Panay N, et al.
Maturitas . 2022 Jun; 161:18-26. PMID: 35688490
Objective: To compare the difference between micronised progesterone (MP) and medroxyprogesterone acetate (MPA) in combination with transdermal oestradiol (t-E) on cardiovascular disease (CVD) risk markers in women diagnosed with an...
3.
The effect of micronized progesterone and medroxyprogesterone acetate in combination with transdermal estradiol on hemostatic biomarkers in postmenopausal women diagnosed with POI and early menopause: a randomized trial
Mittal M, Chitongo P, Supramaniam P, Cardozo L, Savvas M, Panay N, et al.
Menopause . 2022 Apr; 29(5):580-589. PMID: 35486948
Objective: To compare the impact of micronized progesterone (MP) or medroxyprogesterone acetate (MPA) in combination with transdermal estradiol (t-E2) on traditional coagulation factors and thrombin generation parameters in postmenopausal women...
4.
Fertility preserving management for postpartum haemorrhage secondary to subinvolution of the placental implantation site
Du R, Davies R, Supramaniam P
BMJ Case Rep . 2021 Oct; 14(9). PMID: 34593553
A 40-year-old woman presents with recurrent secondary postpartum haemorrhage (PPH) following her third normal vaginal delivery. Histology from subsequent evacuation of the uterus confirmed that she had subinvolution of the...
5.
Reply: ICSI does not improve reproductive outcomes in autologous ovarian response cycles with non-male factor subfertility
Supramaniam P, Granne I, Ohuma E, Lim L, McVeigh E, Venkatakrishnan R, et al.
Hum Reprod . 2021 May; 36(6):1726-1727. PMID: 33982082
No abstract available.
6.
Is the clinician an independent variable in embryo transfer outcomes under standardized direct and indirect supervision? A 5-year observational cohort study
Mittal M, Supramaniam P, Lim L, Hamoda H, Savvas M, Narvekar N
GMS J Med Educ . 2019 Mar; 36(1):Doc7. PMID: 30828607
To compare the cumulative pregnancy rate (CPR) for experienced clinicians and trainees naive to the skill of embryo transfer (ET) during an assisted reproductive treatment (ART) cycle. To establish the...
7.
The correlation between raised body mass index and assisted reproductive treatment outcomes: a systematic review and meta-analysis of the evidence
Supramaniam P, Mittal M, McVeigh E, Lim L
Reprod Health . 2018 Mar; 15(1):34. PMID: 29486787
Background: Public funding for fertility services within the United Kingdom is limited, and therefore, strict guidance exists regarding who can be offered treatment under the National Health Service (NHS). Body...